Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Javier Hasse

Cannabis Co. Juva Life Secures $11.8M in Financing For Operations Expansion, Clinical Research

Cannabis-focused pharmaceutical research and development and consumer-facing company Juva Life Inc. (CSE:JUVA) (OTCQB:JUVAF) has closed a dilutive financing of $11.8 million, enabling it to acquire its Stockton, California, facility as well as further its clinical research on its two novel compounds.

The dilutive financing, which was closed on June 15, 2022, was facilitated by Pelorus Equity Group, which specializes in real estate debt financing solutions. The primary purpose of the financing was to provide capital to complete the acquisition, appraised at a value of more than $17 million, for a purchase price of $4 million. Additionally, Juva plans to use the funds to further its clinical research development programs on novel compounds Juva-019 and Juva-041, targeting the treatment of inflammation.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.